Open in new window
|
|
Featured News
|
|
eschbach Rolls Out its Shiftconnector Equipment Hub
eschbach has introduced a module, Shiftconnector Equipment Hub.
Read more
|
|
Pharmaindustrial News
|
|
Johnson and Johnson to Obtain Rights to Clinical-Stage Bispecific Antibody
Johnson & Johnson has signed a definitive deal with Numab Therapeutics, to acquire from Numab’s shareholders its wholly-owned subsidiary for the global rights to a novel, investigational...
Read more
|
|
|
Merck Announces Acquisition of EyeBio
Merck has signed a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.
Read more
|
|
|
HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing deal with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
Read more
|
|
|
Helsinn Signs License Deal with Angelini Pharma to Commercialize AULIN and MESULID
Helsinn Group has signed Distribution and Licence Agreement renewal with Angelini Pharma in Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovak Republic for AULIN and MESULID (Nimesulide)...
Read more
|
|
|
MilliporeSigma Unveils First Software for Complete Data Traceability in Microbial QC
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, has rolled out its M-Trace Software and Mobile App, a comprehensive data tracking solution to digitize sterility testing.
Read more
|
|
|
Novartis Presents Interim Analysis of atrasentan Phase III Data
Novartis has presented results from a pre-specified interim analysis of the Phase III ALIGN study of atrasentan, an investigational oral selective endothelin A (ETA) receptor antagonist, in patients...
Read more
|
|
|
Biocon Signs Exclusive Deal for Commercializing Liraglutide in South Korea with Handok
Biocon Ltd. has signed an exclusive licensing and supply agreement with Handok, a specialty pharmaceutical company in South Korea, for the commercialization of its vertically integrated, complex drug...
Read more
|
|
|
Lilly Increases Manufacturing Investment to USD 9 Bn to Boost API Production for Tirzepatide and Pipeline Medicines
This expansion will enhance Lilly's capacity to manufacture active pharmaceutical ingredients (API) for Zepbound® (tirzepatide) injection and Mounjaro® (tirzepatide) injection so that more...
Read more
|
|
|
Strides Announces Best-Ever Financial Results for FY24
Strides Pharma Science Ltd. has published its consolidated financial results for the quarter (Q4FY24) and full year (FY24) ended March 31, 2024.
Read more
|
|
|
LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Read more
|
|
|
eschbach to Showcase Industry 5.0 Software Shiftconnector at ACHEMA
eschbach will be participating at the highly anticipated ACHEMA, one of the chemical industry's premier events.
Read more
|
|
|
PharmaLytica 2024 to Mark a Decade of Excellence and Innovation for Pharma Manufacturing
PharmaLytica Expo has been approaching its milestone 10th edition launch, scheduled from May 30, 2024 to June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.
Read more
|
|
|
Tower Cold Chain Announces its First Sustainability Report
Tower Cold Chain has recently published its first Sustainability Report, highlighting the company’s commitment to Environmental, Social and Governance (ESG) principles.
Read more
|
|
|
Glenmark Signs Exclusive Marketing and Distribution Deal with BeiGene
Glenmark has signed an exclusive marketing and distribution agreement with BeiGene, a global oncology company.
Read more
|
|
|
Sanofi, Formation Bio and OpenAI to Develop AI-Powered Software
Sanofi, Formation Bio and OpenAI have announced their collaboration to build AI-powered software to accelerate drug development and bring new medicines to patients more efficiently.
Read more
|
|
|
Biocon Biologics Gets FDA Approval for Biosimilar Aflibercept for Yesafili
Biocon Biologics Ltd (BBL) has announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili.
Read more
|
|
|
CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia
CASI received a letter from the FDA indicating clearance for the study to proceed, signaling regulatory approval for the advancement of CID-103 into clinical trials.
Read more
|
|
|
Atraverse Medical Receives FDA Clearance for HOTWIRE Radiofrequency Guidewire
This device enables zero exchange left-heart access while also serving as a rail for catheter-based therapy systems.
Read more
|
|
|
Teva Names Matthew Shields as New Executive Vice President
Teva Pharmaceutical Industries Ltd. has appointed Matthew Shields as Executive Vice President of Teva Global Operations (TGO) under manufacturing and supply division
Read more
|
|
|
Lupin Secures ISO 14001 and ISO 45001 Certification for its Indian Sites and Centers
Lupin Ltd. has announced that all 12 of its manufacturing sites, its R&D Center, and its corporate office in India have completed rigorous audits and been certified by DNV for ISO 14001 —...
Read more
|
|
|
Aurora Cannabis Appoints Rajesh Uttamchandani to Board of Directors
Rajesh Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governanc
Read more
|
|
|
Aldevron Inks Strategic Partnership with Acuitas Therapeutics
Aldevron has forged a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for nucleic acid therapeutics based...
Read more
|
|
|
Sartorius, Sanofi to Develop End-to-End Platform for Downstream Process Intensification
Sartorius has joined hands with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.
Read more
|
|
Articles
|
|
LCA Analysis in the Pharmaceutical Industry
Tracking down emissions
Identifying potential savings is like finding the proverbial needle in a haystack: it isn’t easy, but it isn’t impossible...
Read more
|
|
|
|
LCA Analysis in the Pharmaceutical Industry
Tracking down emissions
Identifying potential savings is like finding the proverbial needle in a haystack: it isn’t easy, but it isn’t impossible...
Read more
|
|
|
Critical Fluid Transfer Applications in Biopharmaceutical Industry
As a definition, any biological macromolecule or cellular component that is able to exert or enhance a therapeutic, curative or protective property can be considered...
Read more
|
|
|
Charting Indias Quest for Innovation in Drug Discovery and Personalised Medicine
India's pharmaceutical sector stands as a global powerhouse, earning the esteemed title of the "Pharmacy of the World" for its unparalleled...
Read more
|
|
Interviews
|
|
Unlocking the Potential of Telomir-1 in Telomere Lengthening with Telomir Pharmaceuticals, Inc.
Q: What is Telomir-1, and how does it work to lengthen DNA's telomere caps?
Dr. Chris Chapman: Telomir-1 is a new chemical entity based on a synthetic...
Read more
|
|
|
|
This message and any attachments are confidential and privileged and intented for the use of the addressee only. If you have received this communication in error, please notify the sender by replay e-mail and delete this message from your system. Please note that Internet e-mail guarantees neither the confidentiality nor the proper receipt of the message sent. The data deriving from our correspondence with you are included in a file of OMNIMEDIA, S.L. which exclusive purpose is to manage the communications of the company; under the understanding that, in maintaining said correspondence, you authorize the treatment of such data for the mentioned purpose. You are entitled to exercise your rights of access, rectification, cancellation and opposition by addressing such written application to address C/ Pollensa, 2, Edif. Artemisa of. 12 de LA ROZAS (28290 - MADRID) enclosing your NIF or identifying document photocopies of.
Unsubscribe
|